| Literature DB >> 34156656 |
Wolfgang Hasemann1,2, Nikki Duncan3,4, Caoimhe Clarke3,4, Eva Nouzova3, Lisa-Marie Süßenbach3, Catriona Keerie5, Valentina Assi5, Christopher J Weir5, Jonathan Evans6, Tim Walsh7, Elizabeth Wilson8, Tara Quasim9, Duncan Middleton10, Alexander J Weir10, Jennifer H Barnett11, David J Stott4, Alasdair M J MacLullich3, Zoë Tieges3,12.
Abstract
PURPOSE: To investigate performance of the Months of the Year Backwards (MOTYB) test in older hospitalised patients with delirium, dementia, and no cognitive impairment.Entities:
Keywords: Attention; Case–control studies; Cognitive dysfunction; Delirium; Dementia
Mesh:
Year: 2021 PMID: 34156656 PMCID: PMC8626373 DOI: 10.1007/s41999-021-00521-4
Source DB: PubMed Journal: Eur Geriatr Med ISSN: 1878-7649 Impact factor: 1.710
Patient characteristics
| Total | Delirium (with or without pre-existing cognitive impairment) | Dementia (no delirium) | No cognitive impairment | |
|---|---|---|---|---|
| 149 | 50 | 46 | 53 | |
| Age median (IQR) | 85.0 (80.0; 88.0) | 87.0 (82.5; 90.0)** | 85.0 (82,0 89.0)** | 82.0 (76.0; 85.0) |
| Gender female (%) | 122 (81.9) | 39 (78.0) | 35 (76.1) | 48 (90.6) |
| CCI | 3.0 (2.0; 5.0) | 4.0 (2.0; 5.0) | 3.0 (2.0; 5.0) | 3.0 (1.0; 4.25) |
Short OMCT (score) (median, IQR) Normal ( Minimal cognitive impairment ( Severe cognitive impairment ( | 11 (3–25) (n = 144) | 3 (0–6)** ( 2 (4%) 7 (15%) 38 (81%) | 6 (2.25–12)** ( 4 (9%) 15 (34%) 25 (57%) | 26 (23.5–28) ( 52 (98%) 1 (2%) |
| AMT10 (score) (median, IQR) | 5 (2–8) ( | 1 (0–4)** ( | 3 (2–6)**† ( | 9 (8–10) ( |
| Brief Attention Test (score) (median, IQR) | 4 (3–6) ( | 2.5 (0–4)** ( | 4 (3–5)**† ( | 6 (6–7) ( |
| DRS-R98 total (score) (median, IQR) | 8 (1–18) ( | 20 (16–23)** ( | 9 (6–12)**† ( | 1 (0–1) ( |
| DRS-R98 severity (score) (median, IQR) | 7 (1–13.75) ( | 16 (11–19) ** ( | 8 (6–11)**† ( | 1 (0–1) ( |
| OSLA (score) (median, IQR) | 0 (0–2.5) ( | 4 (2–6)** ( | 0 (0–1)**† ( | 0 (0–0) ( |
IQR Inter-quartile range, CCI Charlson Comorbidity Index [32]
Short OMCT Short Orientation-Memory-Concentration Test (score range 0–28). Short OMCT categories: severe cognitive impairment (score 0–8), minimal impairment (score 9–20), normal (score > 20)
AMT10 Abbreviated Mental Test-10 (score 0–10, score ≤ 7 indicates cognitive impairment). The Brief Attention Test comprises digit span (3 forward trials, 2 backward trials), months of the year backward and days of the week backward (total score range 0–7, score < 5 indicates attention impairment)
DRS-R98 Delirium Rating Scale-Revised 98 (total score range 0–46 and severity sub-score range 0–39, higher scores indicate increased likelihood and severity of delirium)
OSLA Observational Scale of Level of Arousal (score range 0–15, higher scores indicate more abnormal level of arousal, incorporating both reduced and increased arousal)
**Significantly different to cognitively unimpaired patients at p < 0.003 level after Holm–Bonferroni correction [28]
†Significantly different to patients with delirium at p < 0.003 level after Holm–Bonferroni correction [28]
Worse performance in MOTYB
| Delirium | Dementia | No cognitive impairment | Delirium vs dementia | Delirium vs No cognitive impairmen | Dementia vs No cognitive impairmen | ||||
|---|---|---|---|---|---|---|---|---|---|
| % | % | % | |||||||
| Not meaningfully engage | 23 | 46 | 5 | 11 | 0 | < 0.001** | < 0.001** | 0.02* | |
| Not able to recite to December | 26 | 52 | 7 | 15 | 0 | < 0.001** | < 0.001** | 0.004** | |
| December last correct month | 36 | 72 | 21 | 45 | 0 | 0.012* | < 0.001** | < 0.001** | |
Fisher exact test analyses for delirium versus dementia, delirium versus no cognitive impairment and dementia versus no cognitive impairment
*Lost significance with Holm–Bonferroni correction
**Significant with Holm–Bonferroni correction [28]
Reciting backwards to January for patients being able to meaningfully engage with MOTYB
| Delirium | Dementia | No cognitive impairment | Delirium vs dementia | Delirium vs no cognitive impairment | Dementia vs no cognitive impairment | ||||
|---|---|---|---|---|---|---|---|---|---|
| % | % | % | |||||||
| December to January | 2 | 7 | 8 | 20 | 35 | 66 | 0.29 | < 0.001** | < 0.001** |
Fisher exact test analyses for delirium versus dementia, delirium versus no cognitive impairment and dementia versus no cognitive impairment
**Significant with Holm–Bonferroni correction[28]
Comparison of MOTYB response patterns in patients who are able to meaningfully engage with the task (n = 121)
| Delirium | Dementia | No cognitive impairment | Delirium vs dementia | Delirium vs no cognitive impairment | Dementia vs no cognitive impairment | ||||
|---|---|---|---|---|---|---|---|---|---|
| % | % | % | |||||||
| Error types | |||||||||
| Omission | 7 | (26) | 4 | (10) | 6 | (11) | 0.10 | 0.12 | 1.00 |
| Commission (in wrong place) | 6 | (22) | 15 | (37) | 7 | (13) | 0.29 | 0.35 | 0.01* |
| Commission (non-relevant) | 6 | (22) | 5 | (12) | 0 | (0) | 0.32 | 0.001** | 0.01* |
| Repetition | 5 | (19) | 13 | (32) | 11 | (21) | 0.27 | 1.00 | 0.24 |
| Self-correction | 0 | (0) | 5 | (12) | 6 | (11) | 0.15 | 0.09 | 1.00 |
| Reciting forward | 7 | (26) | 11 | (27) | 1 | (2) | 1.00 | 0.002** | < 0.001** |
| Stopping part way through | 18 | (67) | 22 | (54) | 0 | (0) | 0.32 | < 0.001** | < 0.001** |
Fisher exact test analyses for delirium versus dementia, delirium versus no cognitive impairment and dementia versus no cognitive impairment
*Lost significance with Holm–Bonferroni correction[28]
**Significant with Holm–Bonferroni correction[28]
Fig. 1Last correct month in MOTYB in 149 patients. 2 patients without cognitive impairment, 14 with dementia and 10 with delirium (with and without dementia) stated December as the last correct month in MOTYB. Additionally, out of 50 patients with delirium, 26 could not state December as the last correct month. Of those 3 were able and 23 were unable to meaningfully engage with MOTYB. Out of 46 patients with dementia (without delirium), 7 could not state December as the last correct month. Of those, 2 were able and 5 were unable to meaningfully engage with MOTYB
Fig. 2Flow chart synthesising the clinical approach from Fig 1 and Tables 2–4